Literature DB >> 11106788

The endocannabinoid system: a physiological perspective on its role in psychomotor control.

A Giuffrida1, D Piomelli.   

Abstract

The discovery of cannabinoid receptors has led to the identification of two natural activators for these receptors, anandamide and 2-arachidonoylglycerol, and to the elucidation of their biochemical pathways of formation and inactivation. Although the physiological significance of the endogenous cannabinoid system is still poorly understood, important information is becoming available on the possible functional roles of this system in the basal ganglia, a forebrain region that is involved in the control of sensorimotor and motivational aspects of behavior. These discoveries - which are going to enrich the way in which we look at basal ganglia functions - are summarized in this mini-review. The role of the endocannabinoids as modulators of psychomotor behaviors and the potential therapeutic perspectives deriving from the pharmacological manipulation of the endogenous cannabinoid system are also discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11106788     DOI: 10.1016/s0009-3084(00)00193-6

Source DB:  PubMed          Journal:  Chem Phys Lipids        ISSN: 0009-3084            Impact factor:   3.329


  8 in total

Review 1.  [The endogenous cannabinoid system. Therapeutic implications for neurologic and psychiatric disorders].

Authors:  U Schneider; J Seifert; M Karst; J Schlimme; K Cimander; K R Müller-Vahl
Journal:  Nervenarzt       Date:  2005-09       Impact factor: 1.214

Review 2.  Cannabinoids and neuroprotection in basal ganglia disorders.

Authors:  Onintza Sagredo; Moisés García-Arencibia; Eva de Lago; Simone Finetti; Alessandra Decio; Javier Fernández-Ruiz
Journal:  Mol Neurobiol       Date:  2007-06-23       Impact factor: 5.590

Review 3.  Interactions between the endocannabinoid and nicotinic cholinergic systems: preclinical evidence and therapeutic perspectives.

Authors:  Maria Scherma; Anna Lisa Muntoni; Miriam Melis; Liana Fattore; Paola Fadda; Walter Fratta; Marco Pistis
Journal:  Psychopharmacology (Berl)       Date:  2016-01-04       Impact factor: 4.530

4.  AM404 attenuates reinstatement of nicotine seeking induced by nicotine-associated cues and nicotine priming but does not affect nicotine- and food-taking.

Authors:  Islam Gamaleddin; Mihail Guranda; Maria Scherma; Walter Fratta; Alexandros Makriyannis; Subramanian K Vadivel; Steven R Goldberg; Bernard Le Foll
Journal:  J Psychopharmacol       Date:  2013-02-20       Impact factor: 4.153

Review 5.  Cannabinoids, endocannabinoids, and related analogs in inflammation.

Authors:  Sumner H Burstein; Robert B Zurier
Journal:  AAPS J       Date:  2009-02-06       Impact factor: 4.009

Review 6.  Maturation of amygdala inputs regulate shifts in social and fear behaviors: A substrate for developmental effects of stress.

Authors:  Nicole C Ferrara; Sydney Trask; J Amiel Rosenkranz
Journal:  Neurosci Biobehav Rev       Date:  2021-02-10       Impact factor: 9.052

7.  Anandamide uptake by synaptosomes from human, mouse and rat brain: inhibition by glutamine and glutamate.

Authors:  Natalia Battista; Monica Bari; Alessandro Finazzi-Agrò; Mauro Maccarrone
Journal:  Lipids Health Dis       Date:  2002-09-03       Impact factor: 3.876

Review 8.  Dietary factors in the etiology of Parkinson's disease.

Authors:  Zeynep S Agim; Jason R Cannon
Journal:  Biomed Res Int       Date:  2015-01-20       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.